Human host defense peptide LL-37 stimulates virulence factor production and adaptive resistance in Pseudomonas aeruginosa.
Strempel. Nikola N; Neidig. Anke A; Nusser. Michael M; Geffers. Robert R; Vieillard. Julien J; Lesouhaitier. Olivier O; Brenner-Weiss. Gerald G; Overhage. Joerg J
Key Findings
- Physiological levels of LL‑37 increase production of several P. aeruginosa virulence factors (quorum‑sensing molecules, toxins, elastase, rhamnolipids).
- LL‑37 exposure triggers up‑regulation of multidrug efflux pump genes, leading to reduced susceptibility to gentamicin and ciprofloxacin.
- The bacterial regulator PqsE appears to act as a specific sensor for LL‑37, linking the peptide to the observed increase in virulence and resistance.
Practical Outcomes
- For biohackers considering LL‑37 supplementation or using related cationic peptides, this research suggests a potential risk of promoting harmful bacterial infections and antibiotic resistance. It advises caution and highlights the need for more safety data before incorporating LL‑37 into health protocols.
Summary
The study found that the human antimicrobial peptide LL‑37, at normal body levels, can actually make the bacteria Pseudomonas aeruginosa more aggressive and harder to kill with common antibiotics. This means that taking LL‑37 or similar peptides might unintentionally boost harmful bacterial activity rather than protect you.
Abstract
A multitude of different virulence factors as well as the ability to rapidly adapt to adverse environmental conditions are important features for the high pathogenicity of Pseudomonas aeruginosa. Both virulence and adaptive resistance are tightly controlled by a complex regulatory network and respond to external stimuli, such as host signals or antibiotic stress, in a highly specific manner. Here, we demonstrate that physiological concentrations of the human host defense peptide LL-37 promote virulence factor production as well as an adaptive resistance against fluoroquinolone and aminoglycoside antibiotics in P. aeruginosa PAO1. Microarray analyses of P. aeruginosa cells exposed to LL-37 revealed an upregulation of gene clusters involved in the production of quorum sensing molecules and secreted virulence factors (PQS, phenazine, hydrogen cyanide (HCN), elastase and rhamnolipids) and in lipopolysaccharide (LPS) modification as well as an induction of genes encoding multidrug efflux pumps MexCD-OprJ and MexGHI-OpmD. Accordingly, we detected significantly elevated levels of toxic metabolites and proteases in bacterial supernatants after LL-37 treatment. Pre-incubation of bacteria with LL-37 for 2 h led to a decreased susceptibility towards gentamicin and ciprofloxacin. Quantitative Realtime PCR results using a PAO1-pqsE mutant strain present evidence that the quinolone response protein and virulence regulator PqsE may be implicated in the regulation of the observed phenotype in response to LL-37. Further experiments with synthetic cationic antimicrobial peptides IDR-1018, 1037 and HHC-36 showed no induction of pqsE expression, suggesting a new role of PqsE as highly specific host stress sensor.
Study Information
pubmed
2013
2013-12-13T00:00:00.000Z
10.1371/journal.pone.0082240
72
68